Phase 2 Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older, of any gender.
- People whose nerve pain has been present and is linked to chemotherapy treatment involving platinum-based drugs, taxane-based drugs, or both.
- People who have completed a chemotherapy treatment that included taxane or platinum drugs, and whose cancer is not currently showing signs of getting worse or spreading.
Who may not be able to join:
- People whose nerve pain symptoms are similar to chemotherapy-related nerve pain but are caused by something other than platinum or taxane chemotherapy.
- People who have received a treatment called HAL at any point before the screening stage of this trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 866-620-9255
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
NRS Pain; Safety Assessments
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.